In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From ANGLE plc

Angle Outlines Strategy As It Nears Major Regulatory Announcements

With approvals looming over the next few months, Angle spoke to Medtech Insight to probe deeper about its presentation at the 2021 Jefferies Healthcare Conference.

In Vitro Diagnostics Personalized Medicine

Angle Is Ready To Capitalize On Promise Of Capture Cell Technology

Angle PLC has published half year interim results which indicate it will capitalize on a new liquid biopsy market.

In Vitro Diagnostics Approvals

Angle Will Reshape Liquid Diagnostics By Capturing Circulating Tumor Cells

Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis

In Vitro Diagnostics Cancer

Angle Files De Novo Submission For Parsortix System In Breast Cancer

The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.

Cancer Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Axela Inc.
UsernamePublicRestriction

Register